Alaunos Therapeutics Corporate Secretary Melinda Lackey to depart August 15, 2025

Alaunos Therapeutics, Inc.

Melinda Lackey notified company on 7/16/2025 of termination of consulting agreement effective 8/15/2025.
She will resign as Legal and Administrative Officer and Corporate Secretary on the effective date.
Departure not due to any disagreement with the company on operations, policies, or procedures.
No additional severance beyond accrued but unpaid compensation through effective date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.